Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
Abstract Esophageal cancer is a malignant type of cancer with a high mortality rate. The aim of this study is to determine co-expression patterns of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in ESCC (esophageal squamous cell carcinoma) conditio...
Main Authors: | Lingzhao Li, Narasimha M. Beeraka, Linsen Xie, Li Dong, Junqi Liu, Lei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-07-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00527-9 |
Similar Items
-
HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01) -
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01) -
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
by: Harbinder Singh, et al.
Published: (2022-10-01) -
Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury
by: Biying Qian, et al.
Published: (2020-03-01) -
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
by: Strohbuecker L, et al.
Published: (2019-02-01)